David A. Siegel Care Dx, Inc. Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Care Dx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 210,200 shares of CDNA stock, worth $3.15 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
210,200
Previous 342,100
38.56%
Holding current value
$3.15 Million
Previous $6.07 Million
32.36%
% of portfolio
0.01%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding CDNA
# of Institutions
211Shares Held
55.8MCall Options Held
85KPut Options Held
33.1K-
Black Rock Inc. New York, NY5.29MShares$79.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$73.6 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA2.54MShares$38.1 Million0.01% of portfolio
-
Bamco Inc New York, NY2.44MShares$36.5 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$32.7 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $801M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...